Entrada Therapeutics, Inc. (Nasdaq: TRDA) will announce topline results from Cohort 1 of the double-blind, placebo-controlled, multiple ascending dose portion of the Phase 1/2 ELEVATE-44-201 clinical ...
REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a webcast on Thursday, May 14, 2026, at 8:00 a.m. ET to discuss topline results from the pivotal trial of RGX-202, the company's ...
Everyday Health on MSN
The independence blueprint: Managing mobility challenges with Duchenne muscular dystrophy
Managing the transition to mobility aids is a pivotal part of life with DMD. Discover expert strategies for maintaining ...
One of the most well-known Flying Pig racers just finished his 15th marathon. Diego Ramirez has Duchenne muscular dystrophy ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine Today, the world stands at a crossroads in genetic medicine ...
Twin brothers Daniel and Matt Murray of Buffalo are preparing to take on three marathons together to raise awareness and ...
The muscular dystrophies are commonly associated with cardiovascular complications, including cardiomyopathy and cardiac arrhythmias. These complications are caused by intrinsic defects in ...
We hypothesize that Duchenne muscular dystrophy and autism spectrum disorder/pervasive developmental disorder co-occur with a greater than random frequency. In this study, we set out to reject the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results